BACKGROUND: Comorbidities play a key role in severe disease outcomes in COVID-19 patients. However, the literature on preexisting respiratory diseases and COVID-19, accounting for other possible confounders, is limited. The primary objective of this study was to determine the association between preexisting respiratory diseases and severe disease outcomes among COVID-19 patients. Secondary aim was to investigate any correlation between smoking and clinical outcomes in COVID-19 patients. METHODS: This is a multihospital retrospective cohort study on 1871 adult patients between March 10, 2020, and June 30, 2020, with laboratory confirmed COVID-19 diagnosis. The main outcomes of the study were severe disease outcomes i.e. mortality, need for mechanical ventilation, and intensive care unit (ICU) admission. During statistical analysis, possible confounders such as age, sex, race, BMI, and comorbidities including, hypertension, coronary artery disease, congestive heart failure, diabetes, any history of cancer and prior liver disease, chronic kidney disease, end-stage renal disease on dialysis, hyperlipidemia and history of prior stroke, were accounted for. RESULTS: A total of 1871 patients (mean (SD) age, 64.11 (16) years; 965(51.6%) males; 1494 (79.9%) African Americans; 809 (43.2%) with ≥ 3 comorbidities) were included in the study. During their stay at the hospital, 613 patients (32.8%) died, 489 (26.1%) needed mechanical ventilation, and 592 (31.6%) required ICU admission. In fully adjusted models, patients with preexisting respiratory diseases had significantly higher mortality (adjusted Odds ratio (aOR), 1.36; 95% CI, 1.08-1.72; p = 0.01), higher rate of ICU admission (aOR, 1.34; 95% CI, 1.07-1.68; p = 0.009) and increased need for mechanical ventilation (aOR, 1.36; 95% CI, 1.07-1.72; p = 0.01). Additionally, patients with a history of smoking had significantly higher need for ICU admission (aOR, 1.25; 95% CI, 1.01-1.55; p = 0.03) in fully adjusted models. CONCLUSION: Preexisting respiratory diseases are an important predictor for mortality and severe disease outcomes, in COVID-19 patients. These results can help facilitate efficient resource allocation for critical care services.
BACKGROUND: Comorbidities play a key role in severe disease outcomes in COVID-19patients. However, the literature on preexisting respiratory diseases and COVID-19, accounting for other possible confounders, is limited. The primary objective of this study was to determine the association between preexisting respiratory diseases and severe disease outcomes among COVID-19patients. Secondary aim was to investigate any correlation between smoking and clinical outcomes in COVID-19patients. METHODS: This is a multihospital retrospective cohort study on 1871 adult patients between March 10, 2020, and June 30, 2020, with laboratory confirmed COVID-19 diagnosis. The main outcomes of the study were severe disease outcomes i.e. mortality, need for mechanical ventilation, and intensive care unit (ICU) admission. During statistical analysis, possible confounders such as age, sex, race, BMI, and comorbidities including, hypertension, coronary artery disease, congestive heart failure, diabetes, any history of cancer and prior liver disease, chronic kidney disease, end-stage renal disease on dialysis, hyperlipidemia and history of prior stroke, were accounted for. RESULTS: A total of 1871 patients (mean (SD) age, 64.11 (16) years; 965(51.6%) males; 1494 (79.9%) African Americans; 809 (43.2%) with ≥ 3 comorbidities) were included in the study. During their stay at the hospital, 613 patients (32.8%) died, 489 (26.1%) needed mechanical ventilation, and 592 (31.6%) required ICU admission. In fully adjusted models, patients with preexisting respiratory diseases had significantly higher mortality (adjusted Odds ratio (aOR), 1.36; 95% CI, 1.08-1.72; p = 0.01), higher rate of ICU admission (aOR, 1.34; 95% CI, 1.07-1.68; p = 0.009) and increased need for mechanical ventilation (aOR, 1.36; 95% CI, 1.07-1.72; p = 0.01). Additionally, patients with a history of smoking had significantly higher need for ICU admission (aOR, 1.25; 95% CI, 1.01-1.55; p = 0.03) in fully adjusted models. CONCLUSION: Preexisting respiratory diseases are an important predictor for mortality and severe disease outcomes, in COVID-19patients. These results can help facilitate efficient resource allocation for critical care services.
Authors: Shruti Gupta; Salim S Hayek; Wei Wang; Lili Chan; Kusum S Mathews; Michal L Melamed; Samantha K Brenner; Amanda Leonberg-Yoo; Edward J Schenck; Jared Radbel; Jochen Reiser; Anip Bansal; Anand Srivastava; Yan Zhou; Anne Sutherland; Adam Green; Alexandre M Shehata; Nitender Goyal; Anitha Vijayan; Juan Carlos Q Velez; Shahzad Shaefi; Chirag R Parikh; Justin Arunthamakun; Ambarish M Athavale; Allon N Friedman; Samuel A P Short; Zoe A Kibbelaar; Samah Abu Omar; Andrew J Admon; John P Donnelly; Hayley B Gershengorn; Miguel A Hernán; Matthew W Semler; David E Leaf Journal: JAMA Intern Med Date: 2020-11-01 Impact factor: 21.873
Authors: Brian E Cade; Hassan S Dashti; Syed M Hassan; Susan Redline; Elizabeth W Karlson Journal: Am J Respir Crit Care Med Date: 2020-11-15 Impact factor: 21.405
Authors: Janice M Leung; Chen X Yang; Anthony Tam; Tawimas Shaipanich; Tillie-Louise Hackett; Gurpreet K Singhera; Delbert R Dorscheid; Don D Sin Journal: Eur Respir J Date: 2020-05-14 Impact factor: 16.671
Authors: Eusebi Chiner-Vives; Rosa Cordovilla-Pérez; David de la Rosa-Carrillo; Marta García-Clemente; José Luis Izquierdo-Alonso; Remedios Otero-Candelera; Luis Pérez-de Llano; Jacobo Sellares-Torres; José Ignacio de Granda-Orive Journal: Arch Bronconeumol Date: 2022-04-15 Impact factor: 6.333
Authors: Frances Chung; Rida Waseem; Chi Pham; Thomas Penzel; Fang Han; Bjørn Bjorvatn; Charles M Morin; Brigitte Holzinger; Colin A Espie; Christian Benedict; Jonathan Cedernaes; Tarja Saaresranta; Yun Kwok Wing; Michael R Nadorff; Yves Dauvilliers; Luigi De Gennaro; Guiseppe Plazzi; Ilona Merikanto; Kentaro Matsui; Damien Leger; Mariusz Sieminski; Sergio Mota-Rolim; Yuichi Inoue; Markku Partinen Journal: Sleep Breath Date: 2021-04-28 Impact factor: 2.816
Authors: Alice B S Nono Djotsa; Drew A Helmer; Catherine Park; Kristine E Lynch; Amir Sharafkhaneh; Aanand D Naik; Javad Razjouyan; Christopher I Amos Journal: Healthcare (Basel) Date: 2022-07-04